Catherine Hyams

Respiratory Doctor, Clinical Research Fellow @BristolUni | PhD in Respiratory Infection | PI AvonCAP Study | Pulm Infection SAG @btsrespiratory

[Catherine Hyams @cathyams]

@Eurosurveillanc @AChatzilena @adamhfinn @leondanon @BristolUncover @BristolUni @uhbwNHS @NorthBristolNHS Our findings support the booster immunisation programmes implemented in several European countries, that advised the use of #BA1/ancestral #mRNA #bivalent booster doses in individuals at high risk of severe #COVID19
https://t.co/j51u0FU5kW
@AChatzilena @leondanon @adamhfinn

[Catherine Hyams @cathyams]

@tb_doc @HugoResp @NHSBartsHealth For a review/summary article:
https://t.co/9gGYRnGUFP

[Leon @leondanon]

So pleased this one is out: https://t.co/BIXtFIYMfY
Multiplex panel tests have an inherent uncertainty that is typically ignored when calculating prevalence, and develop methods to fix it. w @rjchallen @adamhfinn @cathyams @AChatzilena @KrasiTsaneva

[Catherine Hyams @cathyams]

@Eurosurveillanc @AChatzilena @adamhfinn @leondanon @BristolUncover @BristolUni @uhbwNHS @NorthBristolNHS This work from AvonCAP couldn't be done without the amazing @ResearchNBT @uhbwNHS #NHS & research team, working collaboratively with @BristolUni, @UKHSA & academics

[Catherine Hyams @cathyams]

Understanding protection from #COVID19 boosters against #SARSCoV2 infection is a priority. We compared protection against hospitalisation in 2022 UK booster campaigns: original monovalent mRNA vaccine vs bivalent mRNA booster
@leondanon @AChatzilena @adamhfinn @BristolUncover

[Catherine Hyams @cathyams]

@Eurosurveillanc @AChatzilena @adamhfinn @leondanon @BristolUncover @BristolUni @uhbwNHS @NorthBristolNHS Our findings support the booster immunisation programmes implemented in several European countries, that advised the use of #BA1/ancestral #mRNA #bivalent booster doses in individuals at high risk of severe #COVID19
https://t.co/j51u0FU5kW
@AChatzilena @leondanon @adamhfinn

[Catherine Hyams @cathyams]

@alice_ahalliday @AshToye_Bristol @BristolARU @BristolUni @leondanon @rjchallen @BristolUncover This analysis provides evidence blood group status may influence outcome of respiratory infection: group A have increased risk of hospitalisation & RhD-positive patients having reduced cardiovascular complications.
@adamhfinn @BristolUni @BristolIandI
https://t.co/9Pd91OSoCY

[Catherine Hyams @cathyams]

What effect does ABO & Rhesus status have on outcomes with respiratory infection?
Read the paper from @alice_ahalliday and @AshToye_Bristol and AvonCAP, @BristolARU and @BristolUni to find out!
https://t.co/9Pd91OSoCY

[Catherine Hyams @cathyams]

@alice_ahalliday @AshToye_Bristol @BristolARU @BristolUni We found blood group A and Rh neg patients were over represented in respiratory infection.
ABO group didn't influence cardiovascular complication risk; but, RhD-positive pneumonia patient had reduced risk of cardiovascular complications
@leondanon @rjchallen @BristolUncover

[Alice Hathaway @AliceHathaaa]

Excited to share my first paper from my
@TheBHF PhD on ABO & Rh blood groups on respiratory infection hospitalisation & outcome! Huge thanks to my supervisors @cathyams & @AshToye_Bristol & the AvonCAP research team for making this possible 👩‍🔬https://t.co/BfvvatOb5T

[Ash @AshToye_Bristol]

Great to see this blood groups and non-SARS-CoV2 respiratory infection paper out by our @TheBHF funded PhD student @AliceHathaaa in a continuation of our Avon CAP Research team collaboration with @adamhfinn @cathyams https://t.co/fNggsQyQel

[EID journal @EIDjournal]

#CMEActivity, Serotype distribution and disease severity in adults hospitalized with #Streptococcus #pneumoniae infection, Bristol and Bath, UK, 2006‒2022, EID journal, https://t.co/q9LfCItY9B (Authors: @cathyams, Robert Challen)

[Catherine Hyams @cathyams]

Super excited!! Our paper on #pneumococcal #serotypes was accepted in @EIDjournal More like unbelievably excited... Keeping calm... Obviously not
@adamhfinn @BristolARU @leondanon @rjchallen @BristolUni @ResearchNBT @BristolUncover @UKHSA @ShamezLadhani
https://t.co/IjHDGHCZqT

[The BMA @TheBMA]

Rishi Sunak said today at #PMQs that rising NHS waiting lists is down to industrial action.

Well how about the last 13 years of rising waiting lists?

[Catherine Hyams @cathyams]

As always, this important work cannot be undertaken without the fantastic #NHS and @UKHSA, and the people who collaborate to deliver #research that we hope makes #meaningful change

@BristolARU @NorthBristolNHS @uhbwNHS @BristolUni @BristolUncover @adamhfinn @theotherdodd @pfizer

[Catherine Hyams @cathyams]

Are #COPD #exacerbations due to #SARSCoV2 more severe than those due to other infections or non-infectious causes?
Our latest paper in @EditorJRSM tries to address this question.
@theotherdodd @adamhfinn @leondanon @rjchallen @BristolARU @BristolUni
https://t.co/ARjrtZ8JP8

[Catherine Hyams @cathyams]

We also found a 9.8% 30-day mortality rate among non #SARSCoV2 #COPD patients, highlighting the burden of #COPD during the #COVID19 #pandemic. #COPD COPD exacerbation-related morbidity and mortality remain substantial, and there's much work to do.

@theotherdodd @BristolARU